Wall Street brokerages expect Quidel Co. (NASDAQ:QDEL) to announce ($0.14) earnings per share (EPS) for the current quarter, according to Zacks. Three analysts have made estimates for Quidel’s earnings. Quidel posted earnings per share of ($0.06) during the same quarter last year, which indicates a negative year-over-year growth rate of 133.3%. The company is expected to report its next quarterly earnings results after the market closes on Wednesday, February 21st.
According to Zacks, analysts expect that Quidel will report full year earnings of ($0.23) per share for the current financial year. For the next financial year, analysts expect that the business will report earnings of $1.24 per share. Zacks Investment Research’s earnings per share calculations are a mean average based on a survey of analysts that follow Quidel.
QDEL has been the topic of a number of recent research reports. Canaccord Genuity reissued a “buy” rating and set a $52.00 target price (up from $48.00) on shares of Quidel in a research report on Thursday, December 21st. BidaskClub cut shares of Quidel from a “buy” rating to a “hold” rating in a research report on Wednesday, January 31st. Zacks Investment Research cut shares of Quidel from a “hold” rating to a “strong sell” rating in a research report on Thursday, December 28th. Piper Jaffray Companies reissued a “buy” rating and set a $60.00 target price on shares of Quidel in a research report on Wednesday, January 24th. Finally, Barclays boosted their target price on shares of Quidel from $45.00 to $49.00 and gave the stock an “overweight” rating in a research report on Thursday, November 2nd. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and six have given a buy rating to the company. Quidel presently has a consensus rating of “Buy” and a consensus target price of $53.50.
Quidel (NASDAQ:QDEL) traded up $0.77 during midday trading on Friday, hitting $45.87. 191,954 shares of the stock were exchanged, compared to its average volume of 334,712. Quidel has a twelve month low of $20.43 and a twelve month high of $49.47. The company has a current ratio of 6.28, a quick ratio of 5.68 and a debt-to-equity ratio of 0.70. The firm has a market capitalization of $1,533.26, a PE ratio of -305.78, a P/E/G ratio of 1.45 and a beta of 1.02.
In related news, SVP Werner Kroll sold 16,358 shares of the company’s stock in a transaction on Friday, December 8th. The shares were sold at an average price of $40.44, for a total value of $661,517.52. Following the sale, the senior vice president now directly owns 10,818 shares of the company’s stock, valued at $437,479.92. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Douglas C. Bryant sold 12,000 shares of the company’s stock in a transaction on Tuesday, November 28th. The shares were sold at an average price of $36.72, for a total transaction of $440,640.00. Following the completion of the sale, the chief executive officer now directly owns 296,493 shares in the company, valued at $10,887,222.96. The disclosure for this sale can be found here. Insiders sold 370,260 shares of company stock worth $15,293,980 over the last ninety days. 22.00% of the stock is currently owned by corporate insiders.
A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Teachers Advisors LLC raised its holdings in shares of Quidel by 10.9% during the second quarter. Teachers Advisors LLC now owns 54,932 shares of the company’s stock worth $1,491,000 after purchasing an additional 5,395 shares during the period. TIAA CREF Investment Management LLC raised its holdings in shares of Quidel by 1.1% during the second quarter. TIAA CREF Investment Management LLC now owns 99,227 shares of the company’s stock worth $2,693,000 after purchasing an additional 1,062 shares during the period. Northern Trust Corp raised its holdings in shares of Quidel by 6.9% during the second quarter. Northern Trust Corp now owns 377,707 shares of the company’s stock worth $10,250,000 after purchasing an additional 24,453 shares during the period. Vanguard Group Inc. raised its holdings in shares of Quidel by 3.2% during the second quarter. Vanguard Group Inc. now owns 2,195,101 shares of the company’s stock worth $59,575,000 after purchasing an additional 68,549 shares during the period. Finally, Voya Investment Management LLC raised its holdings in shares of Quidel by 11.1% during the second quarter. Voya Investment Management LLC now owns 13,636 shares of the company’s stock worth $370,000 after purchasing an additional 1,366 shares during the period. 92.26% of the stock is currently owned by hedge funds and other institutional investors.
TRADEMARK VIOLATION NOTICE: “Quidel Co. (QDEL) Expected to Post Earnings of -$0.14 Per Share” was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this piece on another publication, it was illegally copied and reposted in violation of US & international trademark and copyright legislation. The legal version of this piece can be read at https://www.dispatchtribunal.com/2018/02/17/quidel-co-qdel-expected-to-post-earnings-of-0-14-per-share.html.
Quidel Company Profile
Quidel Corporation is engaged in the development, manufacturing and marketing of diagnostic testing solutions. These diagnostic testing solutions are separated into four product categories: immunoassays, molecular assays, virology and specialty products. The Company sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics, pharmacies and wellness screening centers.
Get a free copy of the Zacks research report on Quidel (QDEL)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Quidel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quidel and related companies with MarketBeat.com's FREE daily email newsletter.